Alarcon Manchego Peter, Cheung Michael, Zannino Diana, Nunn Russell, D'Udekem Yves, Brizard Christian
Department of Cardiology, The Royal Children's Hospital Melbourne.
Department of Cardiology, The Royal Children's Hospital Melbourne.
Semin Thorac Cardiovasc Surg. 2018 Spring;30(1):71-78. doi: 10.1053/j.semtcvs.2018.02.013. Epub 2018 Feb 9.
The burden of disease associated with cardiac surgery in preterm and low birth weight infants is increasing. This retrospective study aimed to compare the mortality and morbidity of cardiac surgery in low birth weight and preterm infants with that of a case-matched normal population. This was a single-center audit of cardiac surgery interventions at a tertiary pediatric center in Melbourne, Australia. Subjects underwent intervention in the first 3 months of life and were preterm (<37 weeks' gestation) or <2500 g at birth. Subjects were case-matched with 2 controls of term gestation and appropriate birth weight with the same primary diagnosis and intervention. Principal outcomes were mortality and complications in the 6 months following intervention. A total of 513 participants were included for analysis in the 13-year study period. There was an increased risk of mortality (odds ratio 6.26; 95% confidence interval (3.19, 12.3)) and rate of complications (odds ratio 2.29; 95% confidence interval (1.38, 3.78)) in low birth weight and premature infants compared with the control population. Patients who did not survive were more likely to have required extracorporeal membrane oxygenation (relative risk [RR] 6.6, P < 0.001), developed postoperative sepsis (RR 2.6, P = 0.012), and undergone unplanned reintervention (RR 2.3, P < 0.001) compared with survivors. Preterm and low birth weight patients had twice the RR of developing complications and 6 times the risk of mortality in the 6 months following cardiac intervention compared with a matched population. Observed trends suggest delaying surgery in clinically stable infants beyond 35 weeks corrected gestational age and 2500-g weight may result in improved survival.
与早产和低出生体重婴儿心脏手术相关的疾病负担正在增加。这项回顾性研究旨在比较低出生体重和早产婴儿心脏手术的死亡率和发病率与病例匹配的正常人群的情况。这是对澳大利亚墨尔本一家三级儿科中心心脏手术干预的单中心审计。研究对象在出生后的前3个月接受了干预,为早产儿(妊娠<37周)或出生时体重<2500克。研究对象与2名足月妊娠且出生体重合适、具有相同主要诊断和干预措施的对照进行病例匹配。主要结局是干预后6个月内的死亡率和并发症。在13年的研究期间,共有513名参与者纳入分析。与对照人群相比,低出生体重和早产婴儿死亡率增加(比值比6.26;95%置信区间[3.19,12.3]),并发症发生率增加(比值比2.29;95%置信区间[1.38,3.78])。与存活者相比,未存活者更有可能需要体外膜肺氧合(相对危险度[RR]6.6,P<0.001)、发生术后败血症(RR 2.6,P=0.012)以及接受计划外再次干预(RR 2.3,P<0.001)。与匹配人群相比,早产和低出生体重患者在心脏干预后6个月发生并发症的RR是其两倍,死亡风险是其6倍。观察到的趋势表明,将临床稳定婴儿的手术推迟至矫正胎龄35周和体重2500克以上,可能会提高存活率。